Effectdossier · gearchiveerd kwartaal
JANX
Janux Therapeutics, Inc. · Healthcare · Biotechnology
12Gevolgde houders
0Δ houders
25.28MGehouden aandelen
$583.88MGerapporteerde waarde
+1Nieuwe posities
−1Uitstappen
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +8.7% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | 0 | 35.14M | $539.55M | +6 | −6 |
| Q1 2026 | 80 | +4 | 31.30M | $434.70M | +12 | −8 |
| Q4 2025 | 75 | +1 | 36.09M | $498.13M | +1 | — |
| Q3 2025 | 15 | 0 | 27.21M | $664.97M | — | — |
| Q2 2025 | 12 | 0 | 25.28M | $583.88M | +1 | −1 |
| Q1 2025 | 9 | -2 | 8.77M | $236.76M | — | −2 |
| Q4 2024 | 11 | 0 | 8.88M | $475.25M | +1 | −1 |
| Q3 2024 | 10 | +1 | 4.53M | $205.89M | +1 | — |
| Q2 2024 | 9 | — | 5.15M | $215.67M | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 8.89M | — | $205.33M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 8.89M | — | $205.33M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 8.89M | — | $205.33M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 8.89M | — | $205.33M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 8.89M | — | $205.33M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 3.40M | — | $78.61M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 3.40M | — | $78.61M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 3.40M | — | $78.61M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 3.40M | — | $78.61M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 3.40M | — | $78.61M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 3.40M | — | $78.61M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 3.40M | — | $78.61M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 3.40M | — | $78.61M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 3.40M | — | $78.61M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 3.40M | — | $78.61M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 3.40M | — | $78.61M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 3.40M | — | $78.61M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 3.40M | — | $78.61M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Adage Capital Partners ✦ | 2.52M | -30.9% | $58.33M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passief) | 2.19M | — | $50.58M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passief) | 2.19M | — | $50.58M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (passief) | 2.19M | — | $50.58M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | The Vanguard Group ✦ (passief) | 2.19M | — | $50.58M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | The Vanguard Group ✦ (passief) | 2.19M | — | $50.58M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Point72 Asset Management ✦ | 2.14M | +469.2% | $49.52M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 26 | T. Rowe Price ✦ | 1.79M | +28.8% | $41.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | T. Rowe Price ✦ | 1.79M | +28.8% | $41.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | State Street Global Advisors ✦ (passief) | 1.39M | +1.2% | $32.07M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 29 | Citadel Advisors ✦ | 1.23M | +74.2% | $28.44M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Citadel Advisors ✦ | 1.23M | +74.2% | $28.44M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Geode Capital Management ✦ (passief) | 902.31K | +15.6% | $20.85M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Geode Capital Management ✦ (passief) | 902.31K | +15.6% | $20.85M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Wellington Management ✦ | 492.36K | +25.1% | $11.37M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Wellington Management ✦ | 492.36K | +25.1% | $11.37M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | Wellington Management ✦ | 492.36K | +25.1% | $11.37M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Wellington Management ✦ | 492.36K | +25.1% | $11.37M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | Wellington Management ✦ | 492.36K | +25.1% | $11.37M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | Wellington Management ✦ | 492.36K | +25.1% | $11.37M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | Wellington Management ✦ | 492.36K | +25.1% | $11.37M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 40 | Millennium Management ✦ | 214.36K | +160.6% | $4.95M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 41 | Two Sigma Investments ✦ | 104.38K | Nieuw | $2.41M | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Two Sigma Investments | $2.41M | 0.0% |
Verlaten
| AQR Capital Management | $262,359 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 188 houders, 59.36M aandelen, $809.28M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API